KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Cash & Current Investments (2016 - 2025)

Exact Sciences has reported Cash & Current Investments over the past 16 years, most recently at $964.7 million for Q4 2025.

  • Quarterly Cash & Current Investments fell 7.06% to $964.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $964.7 million through Dec 2025, down 7.06% year-over-year, with the annual reading at $964.7 million for FY2025, 7.06% down from the prior year.
  • Cash & Current Investments was $964.7 million for Q4 2025 at Exact Sciences, down from $1.0 billion in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $1.4 billion in Q1 2021 and troughed at $213.0 million in Q2 2025.
  • The 5-year median for Cash & Current Investments is $801.6 million (2022), against an average of $869.6 million.
  • Year-over-year, Cash & Current Investments surged 39.04% in 2024 and then crashed 77.5% in 2025.
  • A 5-year view of Cash & Current Investments shows it stood at $1.0 billion in 2021, then crashed by 38.66% to $632.1 million in 2022, then increased by 23.03% to $777.6 million in 2023, then soared by 33.48% to $1.0 billion in 2024, then fell by 7.06% to $964.7 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Cash & Current Investments are $964.7 million (Q4 2025), $1.0 billion (Q3 2025), and $213.0 million (Q2 2025).